US Stock MarketDetailed Quotes
SYRS Syros Pharmaceuticals
- 2.6100
- +0.0500+1.95%
Close Nov 8 16:00 ET
- 2.6593
- +0.0493+1.89%
Post 19:57 ET
70.03MMarket Cap-850P/E (TTM)
2.6800High2.5499Low349.42KVolume2.5700Open2.5600Pre Close912.45KTurnover2.52%Turnover RatioLossP/E (Static)26.83MShares8.170052wk High-6.29P/B36.20MFloat Cap1.430052wk Low--Dividend TTM13.87MShs Float243.7500Historical High--Div YieldTTM5.08%Amplitude1.4300Historical Low2.6110Avg Price1Lot Size
Syros Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -48.07%58.28M | -45.16%78.96M | -34.68%108.3M | -31.03%139.53M | -31.03%139.53M | -54.10%112.22M | 66.87%143.98M | 50.37%165.8M | 55.18%202.3M | 55.18%202.3M |
| -Cash and cash equivalents | -48.07%58.28M | -31.60%78.96M | -20.28%83.52M | -16.68%139.53M | -16.68%139.53M | -34.58%112.22M | 95.45%115.44M | 50.58%104.77M | 81.43%167.47M | 81.43%167.47M |
| -Short-term investments | ---- | ---- | -59.40%24.78M | --0 | --0 | --0 | 4.85%28.54M | 50.02%61.04M | -8.49%34.84M | -8.49%34.84M |
| Receivables | ---- | ---- | ---- | --0 | --0 | -5.99%1.67M | -23.39%1.76M | -44.53%1.77M | -43.14%1.69M | -43.14%1.69M |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | -5.99%1.67M | -23.39%1.76M | -44.53%1.77M | -43.14%1.69M | -43.14%1.69M |
| Other current assets | -34.47%5.66M | -13.57%5.96M | -35.85%3.9M | -26.24%5.45M | -26.24%5.45M | 42.59%8.63M | 104.57%6.89M | 100.26%6.08M | 128.42%7.39M | 128.42%7.39M |
| Total current assets | -47.82%63.93M | -44.36%84.92M | -35.38%112.2M | -31.42%144.98M | -31.42%144.98M | -51.44%122.52M | 66.00%152.63M | 49.08%173.64M | 54.77%211.39M | 54.77%211.39M |
| Non current assets | ||||||||||
| Net PPE | -12.46%17.58M | -20.90%18.22M | -21.25%18.86M | -20.99%19.48M | -20.99%19.48M | -21.76%20.08M | -11.01%23.04M | -10.40%23.95M | -9.62%24.66M | -9.62%24.66M |
| -Gross PPE | -12.46%17.58M | -20.90%18.22M | -21.25%18.86M | -27.13%27.12M | -27.13%27.12M | -21.76%20.08M | -11.01%23.04M | -10.40%23.95M | 0.20%37.22M | 0.20%37.22M |
| -Accumulated depreciation | ---- | ---- | ---- | 39.20%-7.63M | 39.20%-7.63M | ---- | ---- | ---- | -27.38%-12.56M | -27.38%-12.56M |
| Other non current assets | -32.97%3.49M | -32.66%3.58M | -52.55%3.67M | -56.00%3.71M | -56.00%3.71M | -23.01%5.2M | -36.74%5.32M | 23.91%7.73M | 39.94%8.43M | 39.94%8.43M |
| Total non current assets | -16.68%21.06M | -23.11%21.8M | -28.89%22.53M | -29.91%23.19M | -29.91%23.19M | -22.02%25.28M | -17.31%28.35M | -11.02%31.68M | -28.60%33.09M | -28.60%33.09M |
| Total assets | -42.49%85M | -41.03%106.72M | -34.38%134.73M | -31.21%168.17M | -31.21%168.17M | -48.09%147.8M | 43.37%180.98M | 35.01%205.32M | 33.65%244.49M | 33.65%244.49M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 237.86%9.65M | 11.59%7.47M | 305.94%11.35M | 80.07%11.54M | 80.07%11.54M | -78.07%2.86M | 9.29%6.69M | -1.62%2.8M | 73.65%6.41M | 73.65%6.41M |
| -accounts payable | 237.86%9.65M | 11.59%7.47M | 305.94%11.35M | 80.07%11.54M | 80.07%11.54M | -78.07%2.86M | 9.29%6.69M | -1.62%2.8M | 73.65%6.41M | 73.65%6.41M |
| Current accrued expenses | -16.05%11.37M | -12.60%10.74M | -12.62%9.39M | -3.01%9.15M | -3.01%9.15M | -9.47%13.55M | -18.03%12.29M | 6.77%10.75M | 1.69%9.44M | 1.69%9.44M |
| Current debt and capital lease obligation | -33.93%2.58M | 15.03%2.5M | 274.16%14.08M | 334.14%8.99M | 334.14%8.99M | 89.03%3.91M | -75.16%2.17M | 0.86%3.76M | 2.98%2.07M | 2.98%2.07M |
| -Current debt | ---- | ---- | 599.88%11.67M | --6.67M | --6.67M | --1.67M | ---- | 0.00%1.67M | ---- | ---- |
| -Current capital lease obligation | 15.15%2.58M | 15.03%2.5M | 14.99%2.41M | 12.22%2.32M | 12.22%2.32M | 8.46%2.24M | 4.99%2.17M | 1.55%2.1M | 2.98%2.07M | 2.98%2.07M |
| Current deferred liabilities | ---- | ---- | ---- | --0 | --0 | -91.45%139K | -39.15%2.19M | -58.25%3.25M | -57.47%4.33M | -57.47%4.33M |
| Current liabilities | -0.01%28.39M | -13.58%24.52M | 58.39%37.3M | 19.18%36.68M | 19.18%36.68M | -26.10%28.39M | -27.11%28.38M | -14.65%23.55M | -2.32%30.78M | -2.32%30.78M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -1.55%57.64M | -4.11%58.17M | -19.89%47.6M | -13.68%53.08M | -13.68%53.08M | -5.42%58.55M | 8.58%60.66M | -2.87%59.41M | -2.66%61.5M | -2.66%61.5M |
| -Long term debt | 4.25%41.08M | 0.01%40.93M | -24.05%29.71M | -14.99%34.56M | -14.99%34.56M | -2.73%39.41M | 20.50%40.93M | 0.88%39.12M | 0.97%40.65M | 0.97%40.65M |
| -Long term capital lease obligation | -13.49%16.56M | -12.64%17.23M | -11.86%17.89M | -11.14%18.53M | -11.14%18.53M | -10.49%19.14M | -9.91%19.73M | -9.36%20.3M | -9.04%20.85M | -9.04%20.85M |
| Derivative product liabilities | -58.92%10.08M | 62.39%30.39M | 122.80%34.77M | 152.32%61.75M | 152.32%61.75M | -55.55%24.55M | 4,302.82%18.71M | 2,586.23%15.61M | 707.92%24.47M | 707.92%24.47M |
| Total non current liabilities | -18.50%67.73M | 11.57%88.55M | 9.80%82.37M | 33.57%114.83M | 33.57%114.83M | -29.05%83.1M | 41.00%79.37M | 21.50%75.02M | 29.85%85.97M | 29.85%85.97M |
| Total liabilities | -13.79%96.12M | 4.95%113.07M | 21.41%119.67M | 29.77%151.51M | 29.77%151.51M | -28.33%111.49M | 13.16%107.74M | 10.33%98.57M | 19.48%116.75M | 19.48%116.75M |
| Shareholders'equity | ||||||||||
| Share capital | 28.57%27K | 30.00%26K | 30.00%26K | 30.00%26K | 30.00%26K | 5.00%21K | -67.74%20K | -67.21%20K | 233.33%20K | 233.33%20K |
| -common stock | 28.57%27K | 30.00%26K | 30.00%26K | 30.00%26K | 30.00%26K | 5.00%21K | -67.74%20K | -67.21%20K | 233.33%20K | 233.33%20K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -14.86%-756.24M | -21.28%-749.84M | -24.83%-726.52M | -29.48%-722.81M | -29.48%-722.81M | -18.97%-658.42M | -18.17%-618.28M | -19.09%-582.02M | -20.42%-558.23M | -20.42%-558.23M |
| Paid-in capital | 7.25%745.09M | 7.52%743.46M | 7.71%741.55M | 7.81%739.44M | 7.81%739.44M | 1.74%694.7M | 24.70%691.45M | 24.80%688.49M | 24.96%685.85M | 24.96%685.85M |
| Gains losses not affecting retained earnings | ---- | ---- | ---- | --0 | --0 | --0 | 115.65%49K | 196.34%263K | 229.11%102K | 229.11%102K |
| Total stockholders'equity | -130.64%-11.12M | -108.67%-6.35M | -85.90%15.06M | -86.96%16.66M | -86.96%16.66M | -71.90%36.3M | 136.11%73.24M | 70.15%106.75M | 49.89%127.74M | 49.89%127.74M |
| Total equity | -130.64%-11.12M | -108.67%-6.35M | -85.90%15.06M | -86.96%16.66M | -86.96%16.66M | -71.90%36.3M | 136.11%73.24M | 70.15%106.75M | 49.89%127.74M | 49.89%127.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data